eli lilly clinical trials tirzepatide Lilly's showed positive results in late-stage trial as treatment for heart failure Eli Lilly's weight loss drug

Tirzepatide is a medication known for its ability to control blood sugar and aid in weight loss

Confidence: Achieving your ideal body shape will help you look and feel your very best, leading to more confidence

The medication has a 5-day half-life, which means it requires an 8-week washout period to reach undetectable levels in your system at the time of conception

2022;31(5):e4287

First Generic GLP-1 for Obesity Gains FDA Approval The FDA approved Tevas generic Saxenda, the first GLP-1 drug for weight loss, expanding access to obesity treatment

Rybelsus contains semaglutide, the same active ingredient found in Ozempic and Wegovy, but in tablet form